BUZZ-Australia's Cyclopharm soars on diagnostic tech deployment contract

Shares of Cyclopharm CYC.AX up 17.2% at A$2.38

Stock rises as much as 23.2% to A$2.5 in early trade, hitting its highest level since Oct 16, 2023

Radiopharmaceutical firm signs contract with healthcare provider Hospital Corporation of America Healthcare (HCA)

Says contract for deployment of co's Technegas imaging technology in up to 169 nuclear medicine departments across HCA'S network

Co did not provide any transactional details regarding contract

Technegas imaging technology is used to detect pulmonary embolism

More than 502,000 shares change hands, 5.8 times the 30-day avg

Cyclopahrm up 49.5% YTD, including current session's moves

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))